Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
IRIDEX Corporation develops ophthalmic laser systems utilizing proprietary MicroPulse and Endpoint Management technologies for the treatment of glaucoma and retinal diseases. Its product portfolio includes laser consoles, delivery devices, and single-use probes sold primarily to ophthalmologists and healthcare providers worldwide. The company emphasizes innovative, tissue-sparing laser therapies that improve clinical outcomes, safety, and efficiency in treating sight-threatening eye conditions across global markets.
This description was generated via AI from an annual report. Updated about 1 year ago.